loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people...
�we have waited a long time and we cannot possibly wait any longer.�.[email protected].: "fremanezumab for the preventive treatment of chronic migraine.".